{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T00:18:20Z","timestamp":1791418700726,"version":"4.3.3"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Radiat Oncol"],"published-print":{"date-parts":[[2012,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Poly (ADP-ribose) polymerase-1 (PARP-1) is a key enzyme involved in the repair of radiation-induced single-strand DNA breaks. PARP inhibitors such as olaparib (KU-0059436, AZD-2281) enhance tumor sensitivity to radiation and to topoisomerase I inhibitors like camptothecin (CPT). Olaparib is an orally bioavailable inhibitor of PARP-1 and PARP-2 that has been tested in multiple clinical trials. The purpose of this study was to investigate the characteristics of the sensitizing effect of olaparib for radiation and CPT in order to support clinical application of this agent.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>DLD-1 cells (a human colorectal cancer cell line) and H1299 cells (a non-small cell lung cancer cell line) with differences of p53 gene status were used. The survival of these cells was determined by clonogenic assay after treatment with drugs and X-ray irradiation. The \u03b3H2AX focus formation assay was performed to examine the influence of olaparib on induction and repair of double-stranded DNA breaks after exposure to radiation or CPT.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>A radiosensitizing effect of olaparib was seen even at 0.01 \u03bcM. Its radiosensitizing effect after exposure for 2 h was similar to that after 24 h. H1299 cells with depletion or mutation of p53 were more radioresistant than H1299 cells with wild-type p53. However, similar enhancement of radiosensitization by olaparib was observed with all of the tested cell lines regardless of the p53 status. Olaparib also sensitized cells to CPT. This sensitizing effect was seen at low concentrations of olaparib such as 0.01 \u03bcM, and its sensitizing effect was the same at both 0.01 \u03bcM and 1 \u03bcM. The combination of olaparib and CPT had a stronger radiosensitizing effect. The results of the \u03b3H2AX focus assay corresponded with the clonogenic assay findings.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>Olaparib enhanced sensitivity to radiation and CPT at low concentrations and after relatively short exposure times such as 2 h. The radiosensitizing effect of olaprib was not dependent on the p53 status of tumor cells. These characteristics could be advantageous for clinical radiotherapy since tumor cells may be exposed to low concentrations of olaparib and\/or may have different levels of p53 mutation. The combination of olaparib and CPT had a stronger radiosensitizing effect, indicating that combining a PARP inihibitor with a topoiomerase I inhibitor could be promising for clinical radiosensitization.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1748-717x-7-62","type":"journal-article","created":{"date-parts":[[2012,4,23]],"date-time":"2012-04-23T10:27:51Z","timestamp":1335176871000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["The combination of olaparib and camptothecin for effective radiosensitization"],"prefix":"10.1186","volume":"7","author":[{"given":"Katsutoshi","family":"Miura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koh-ichi","family":"Sakata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masanori","family":"Someya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihisa","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideki","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihisa","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masato","family":"Hareyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,4,23]]},"reference":[{"key":"590_CR1","first-page":"16","volume-title":"Radiobiology for the radiologist, ed","author":"EJ Hall","year":"2006","unstructured":"Hall EJ: DNA strand breaks and chromosomal aberrations. In Radiobiology for the radiologist, ed. 6th edition. Edited by: Hall EJ, Giaccia AM. Lippincott Williams & Wilkins, Philadelphia; 2006:16-29.","edition":"6"},{"issue":"16","key":"590_CR2","doi-asserted-by":"publisher","first-page":"7158","DOI":"10.1128\/MCB.25.16.7158-7169.2005","volume":"25","author":"N Saleh-Gohari","year":"2005","unstructured":"Saleh-Gohari N, Bryant HE, Schultz N, Parker KM, Cassel T, Helleday T: Spontaneous homologous recombination is induced by collapsed replication forks that are caused by ebdogenous DNA single-strand breaks. Mol Cell Biol 2005,25(16):7158-7169. 10.1128\/MCB.25.16.7158-7169.2005","journal-title":"Mol Cell Biol"},{"key":"590_CR3","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1042\/bst0310247","volume":"31","author":"KW Caldecott","year":"2003","unstructured":"Caldecott KW: Protein-protein inetractions during mammalian DNA single-strand break repair. Biochem Soc Trans 2003, 31: 247-251.","journal-title":"Biochem Soc Trans"},{"key":"590_CR4","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1093\/bmb\/ldp005","volume":"89","author":"AJ Chalmers","year":"2009","unstructured":"Chalmers AJ: The potential role and application of PARP inhibitors in cancer treatment. Brit Med Bull 2009, 89: 23-40.","journal-title":"Brit Med Bull"},{"issue":"4","key":"590_CR5","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1016\/j.ijrobp.2008.07.031","volume":"72","author":"FA Dungey","year":"2008","unstructured":"Dungey FA, Loser DA, Chalmers AJ: Replication-dependent radiosensitization of human glioma cells by inhibition of poly (ADP-ribose) polymerase: mechanisms and therapeutic potential. Int J Radiat Oncol Biol Phys 2008,72(4):1188-1197. 10.1016\/j.ijrobp.2008.07.031","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"23","key":"590_CR6","doi-asserted-by":"publisher","first-page":"8449","DOI":"10.1158\/1078-0432.CCR-05-1224","volume":"11","author":"LM Smith","year":"2005","unstructured":"Smith LM, Willmore E, Austin CA, Curtin NJ: The novel poly (ADP-ribose) polymerase inhibitor, AG14361, sensitizes celss to topoisomerase I poisons by increasing the persistence of DNA strand breaks. Clin Cancer Res 2005,11(23):8449-8457. 10.1158\/1078-0432.CCR-05-1224","journal-title":"Clin Cancer Res"},{"issue":"2","key":"590_CR7","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1056\/NEJMoa0900212","volume":"361","author":"PC Fong","year":"2009","unstructured":"Fong PC, Boss DS, Timothy A, Tutt A, Wu P, Mergui-Roelvink M, Mortimer P, Swaisland H, Lau A, O\u2019Connor MJ, Ashworth A, Carmichael J, Kaye SB, Schellens JHM, de Bono JS: inhibition of poly (ADP-ribose) polymerase in tumors from BRCA mutation carriers. N Engl J Med 2009,361(2):123-134. 10.1056\/NEJMoa0900212","journal-title":"N Engl J Med"},{"key":"590_CR8","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1016\/j.ijrobp.2004.01.033","volume":"59","author":"Z-H Jin","year":"2004","unstructured":"Jin Z-H, Matsumoto H, Hayashi S, Hatashita M, Ohtsubo T, Shioura H, Kitai R, Kano E: p53-independent thermosensitization by mitomycin c in human non-small-cell cancer cells. Int J Radiat Oncol Biol Phys 2004, 59: 852-860. 10.1016\/j.ijrobp.2004.01.033","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"590_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3191\/thermalmed.26.1","volume":"26","author":"D Kawashima","year":"2010","unstructured":"Kawashima D, Soga M, Takeuchi R, Matsumoto H, Ohtsuka K: Molecular caperone inducers facilitate the functional restoration of temperature-sensitive mutant p53 protein. Thermal Med 2010, 26: 1-17. 10.3191\/thermalmed.26.1","journal-title":"Thermal Med"},{"key":"590_CR10","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/S0027-5107(03)00009-5","volume":"525","author":"SF Yuan","year":"2003","unstructured":"Yuan SF, Chang H, Lee EY: Ionizing radiation-induced Rad51 nuclear focus formation is cell cycle-regulated and defective in both ATM-\/- and c-Abl-\/- cells. Mutat Res 2003, 525: 85-92. 10.1016\/S0027-5107(03)00009-5","journal-title":"Mutat Res"},{"issue":"6","key":"590_CR11","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.1158\/1535-7163.MCT-09-1027","volume":"9","author":"DA Loser","year":"2010","unstructured":"Loser DA, Shibata A, Shibata AK, Woodbine LJ, Jeggo PA, Chalmers AJ: Sensitization to radiation and alkylating agents by inhibitors of poly (ADP-ribose) polymerase is enhanced incells deficient in DNA double-strand break repair. Mol Cacncer ther 2010,9(6):1775-1787. 10.1158\/1535-7163.MCT-09-1027","journal-title":"Mol Cacncer ther"},{"key":"590_CR12","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1093\/jnci\/djm135","volume":"99","author":"O Tredan","year":"2007","unstructured":"Tredan O, Galmarini CM, Patel K, Tannock IF: Drug resistamce and the solid tumor microenvironment. J Natl Cancer Inst 2007, 99: 1441-1454. 10.1093\/jnci\/djm135","journal-title":"J Natl Cancer Inst"},{"key":"590_CR13","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1038\/nature03443","volume":"434","author":"HE Bryant","year":"2005","unstructured":"Bryant HE, Schultz N, Thomas HD, Parker KM, Flower D, Lopez E, Kyle S, Meuth M, Curtin NJ, Helleday T: Specific killing of BRCA2-deficient tumours with inhibitors of poly (ADP-ribose) polymerase. Nature 2005, 434: 913-917. 10.1038\/nature03443","journal-title":"Nature"},{"key":"590_CR14","first-page":"198","volume":"28","author":"WK Sinclair","year":"1968","unstructured":"Sinclair WK: The combined effects of hydroxyurea and x-rays on Chinese hamster cells in vitro. Cancer Res 1968, 28: 198-206.","journal-title":"Cancer Res"},{"issue":"16","key":"590_CR15","first-page":"3667","volume":"53","author":"DG Brachman","year":"1993","unstructured":"Brachman DG, Beckett M, Graves D, Haraf D, Vokes E, Weichselbaum RR: p53 mutation does not correlate with radiosensitivity in 24 head and neck cancer cell lines. Cancer Res 1993,53(16):3667-3669.","journal-title":"Cancer Res"},{"issue":"18","key":"590_CR16","first-page":"4164","volume":"53","author":"WJ Slichenmyer","year":"1993","unstructured":"Slichenmyer WJ, Nelson WG, Slebos RJ, Kastan MB: Loss of a p53-associated G1 checkpoint does not decrease cell survival following DNA damage. Cancer Res 1993,53(18):4164-4168.","journal-title":"Cancer Res"},{"key":"590_CR17","first-page":"60","volume-title":"Radiobiology for the radiologist, ed","author":"EJ Hall","year":"2006","unstructured":"Hall EJ: Repair of radiation damage and the dose-rate effect. In Radiobiology for the radiologist, ed. 6th edition. Edited by: Hall EJ, Giaccia AM. Lippincott Williams & Wilkins, Philadelphia; 2006:60-84.","edition":"6"},{"issue":"2","key":"590_CR18","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/S0360-3016(04)00954-X","volume":"60","author":"A Takahashi","year":"2004","unstructured":"Takahashi A, Matsumoto H, Yuki K, Yasumoto J, Kajiwara A, Aoki M, Furusawa Y, Ohnishi K, Ohnishi T: High-LET radiation enhanced apoptosis but not necrosis regardless of p53 status. Int J Radiat Oncol Biol Phys 2004,60(2):591-597.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"590_CR19","doi-asserted-by":"publisher","first-page":"9390","DOI":"10.1074\/jbc.275.13.9390","volume":"275","author":"EP Rogakou","year":"2000","unstructured":"Rogakou EP, Nieves-Neira W, Boon C, Pommier Y, Bonner WM: Initiation of DNA fragmentation during apoptosis induces phosphorylation of H2AX histone at serine 139. J Biol Chem 2000, 275: 9390-9395. 10.1074\/jbc.275.13.9390","journal-title":"J Biol Chem"},{"key":"590_CR20","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.radonc.2006.07.026","volume":"80","author":"D Klokov","year":"2006","unstructured":"Klokov D, MacPhail SM, Banath JP, Byrne JP, Olove PL: Phosphorylated histone H2AX in trlation to cell survival in tumor cells and xenografts exposed to single and fractionated doses of X-rays. Radiother Oncol 2006, 80: 223-229. 10.1016\/j.radonc.2006.07.026","journal-title":"Radiother Oncol"},{"key":"590_CR21","doi-asserted-by":"publisher","first-page":"125","DOI":"10.2307\/3579762","volume":"151","author":"CY Guo","year":"1999","unstructured":"Guo CY, D\u2019Anna JA, Larner JM: The radiation-induced S-phase checkpoint is independent of CDKN1A. Radiat Res 1999, 151: 125-132. 10.2307\/3579762","journal-title":"Radiat Res"},{"key":"590_CR22","first-page":"4029","volume":"57","author":"R-G Shao","year":"1997","unstructured":"Shao R-G, Cao C-X, Shimizu T, O\u2019Connor PM, Kohn KW, Pommier Y: Abrogation of an S-phase checkpoint and potentiation of camptothecin cytotoxicity by 7-hydroxystaurosporine (UCN-01) in human cancer cell lines, possibly influenced by p53 function. Cancer Res 1997, 57: 4029-4035.","journal-title":"Cancer Res"},{"key":"590_CR23","first-page":"5077","volume":"49","author":"Y-H Hsiang","year":"1989","unstructured":"Hsiang Y-H, Lihou MG, Liu LF: Arrest of replication forks by drug-stabilized topoisomerase I-DNA cleavable complexes as a mechanism of cell killing by camptothecin. Cancer Res 1989, 49: 5077-5082.","journal-title":"Cancer Res"}],"container-title":["Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1748-717X-7-62.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T19:32:02Z","timestamp":1630524722000},"score":1,"resource":{"primary":{"URL":"https:\/\/ro-journal.biomedcentral.com\/articles\/10.1186\/1748-717X-7-62"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4,23]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["590"],"URL":"https:\/\/doi.org\/10.1186\/1748-717x-7-62","relation":{},"ISSN":["1748-717X"],"issn-type":[{"value":"1748-717X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,4,23]]},"assertion":[{"value":"17 October 2011","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2012","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2012","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"62"}}